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ABSTRACT
Although metals have successfully been used as implants for decades, devices
made out of metals do not meet all clinical requirements. For example, metal
objects may interfere with some medical imaging systems (computer tomogra-
phy, magnetic resonance imaging), while their stiffness also differs from natural
bone and may cause stress-shielding and over-loading of bone. There has been a
lot of development in the field of composite biomaterial research, which has
focused to a large extent on biodegradable composites. This overview article
reviews the rationale of using glass fiber-reinforced composite–bioactive glass
(FRC–BG) in cranial implants. For this overview, published scientific articles
with the search term ‘‘bioactive glass cranial implant’’ were collected for having
basis to introduce a novel design of composite implant, which contains bioactive
glass. Additional scientific information was based on articles in the fields of
chemistry, engineering sciences and dentistry. Published articles of the material
properties, biocompatibility and possibility to add bioactive glass to the FRC–
BG implants alongside with the clinical experience as far suggest that there is a
clinical need for bioactive nonmetallic implants. In the FRC–BG implants,
biostable glass fibers are responsible for the load-bearing capacity of the
implant, while the dissolution of the bioactive glass particles supports osteo-
genesis and vascularization and provides antimicrobial properties for the
implant. Material combination of FRC–BG has been used clinically in cranio-
plasty and cranio-maxillo-facial implants, and they have been investigated also
as oral and orthopedic implants. Material combination of FRC–BG has suc-
cessfully been introduced to be a potential implant material in cranial surgery.
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Introduction
It can be estimated that worldwide over 2 million
bone graft procedures, 280,000 hip fractures, 700,000
vertebral, 250,000 wrist fractures and 700,000 various
cranial bone repairs are annually performed [1]. In
particular, the need for skull reconstructions, i.e.,
cranioplasties, is increasing mainly due to an increase
in decompressive craniectomies, a life-saving
maneuver to relieve intracranial pressure resulting
from swelling of the brain due to, for example,
trauma or cerebrovascular accidents. Replacement of
damaged tissues by medical biomaterials after an
injury or disease requires specific properties from the
materials. There is an increasing trend to utilize
nonmetallic materials of polymers, ceramics and
composites rather than metals although metals are
durable and can withstand physiological stress rela-
tively well. Although metal implants have been used
successfully for many years, devices made out of
metals do not meet all biomechanical requirements,
such as isoelasticity of skeleton and bone, and may
lead to insufficient (stress-shielding) or over-loading
situations around the implant [2]. This problem has
been recognized specifically when used as metal
implants in long bones as total hip replacement
implants but in reconstructions of segmental defects
of mandible, lack of isoelasticity may play a role too.
Metal implants may also induce cytotoxic reactions
arising from the release of metal ions, corrosion
products and nanoparticles [3–5]. Potential cytotoxi-
city arising from heavy metal ion liberation and
harmful corrosion products and nanoparticles are
suggested to be harmful for the immunological sys-
tem of human body, which in the case of released
Ti4? ions are causing soft tissue atrophy and poten-
tially exposure of the implants [6]. In addition,
although the most commonly used titanium is not
magnetic metal, all metallic objects interfere with
medical diagnostics when using computer tomogra-
phy, magnetic resonance imaging (MRI) and cone
beam X-ray imaging [7–9]. Metals do not allow
postoperative radiation therapy to be performed
either due to absorption and scattering of the
radiation.
Biodegradable and biostable medical composite
materials have been developed considerably in recent
decades [10]. Currently, they can be used in some
applications in reconstructive medicine. Although
numerous different materials, such as polyethylene
(PE), polymethylmethacrylate (PMMA) and
polyetheretherketone (PEEK) and techniques, have
been and are under investigation, there is not yet the
perfect solution for bone reconstruction because large
number of infections relate to autologous bone flaps
and implants of various materials [9–12]. Paradoxi-
cally, when the metals are radiologically considered
too dense materials, polymers of pf PE, PMMA and
PEEK are having disadvantage of being radiolucent,
which means that that the material cannot be seen
either by conventional X-rays, CTs or MRI images
[11].
Bulk ceramic biomaterials of hydroxyapatite (HA)
and tricalciumphosphate (TCP) have also been tested
as cranial implants [12]. Brittleness of the ceramic
materials especially when the material has been
processed to porous form is a limiting factor for the
clinical use of ceramic materials. Brittleness and low
strength have tried to be resolved by reinforcing the
ceramic with metallic titanium [13].
Durable and tough nonmetallic composites can be
made from high-aspect-ratio fillers, namely fibers
embedded in a polymer matrix. The first studies
using fiber-reinforced composites (FRCs) in medicine
and dentistry occurred in the early 1960s, but more
extensive research started in the early 1990s which
led to introduction of FRCs as reconstructive material
for damaged dental hard tissues [14–18]. The first
approved surgical applications were found in cranial
surgery [18]. To improve osteoconductivity and
osteogenicity of the FRC material, particles of bioac-
tive glass have been added to the surface of FRC
implants or inside the implant [19–23]. Radiopacity of
glass FRC corresponds to that of cortical bone, and
therefore there are no artefacts in the diagnostic
images, but the implant can be seen in the X-rays,
CTs and MRIs (Fig. 1) [24]. Radiation therapy can
also be given in the presence of FRC implant. This
overview describes the present status of the devel-
opment and use of nonmetallic predominantly
biostable glass FRC–BG implants with special
emphasis on cranial bone replacing implants. Table 1
lists properties of cranial implant materials with
respect to their clinically needed properties.
Consequently, because of the need for cranial
implants, which are nonmetallic and bioactive, a
potential material to be used in the cranial implants is
bioactive glass (BG). A review of published scientific
articles in PubMed (US National Library of Medicine,
National Institutes of Health, Bethesda, Maryland,
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USA) with a search word ‘‘bioactive glass cranial
implant’’ that found 45 publications was the basis for
this overview article. Additional scientific informa-
tion was included to this overview from other fields
of sciences, namely from chemistry, engineering sci-
ences and dentistry.
Implant framework
For constructing a durable and nonmetallic implant,
the material should be high in strength (flexural,
impact and tensile strength) and provide good frac-
ture propagation prohibiting properties (toughness).
To reach these mechanical properties, FRC material
consisting of high-aspect ratio reinforcing fibers and
polymer material were used. Presently, the most
commonly used reinforcing fibers in medical and
dental field are made of glass of various compositions
[29–35]. Glass fibers referred as E-glass and S-glass
are basically free of leaching in physiologically moist
environment like in living tissues with the presence
of extracellular liquid. Nominal composition (in wt%)
of commonly used E-glass is SiO2 55; Al2O3 ? Fe2O3
14.5; CaO 21.5; MgO 0.5%; Na2O ? K2O\ 1.0; B2O3
7.5, and for S-glass SiO2 62–65; Al2O3 20-25; MgO
10–15; B2O3 0–1.2; Na2O 0–1.1; Fe2O3 0.2.
Glass fibers of diameter 15–17 micrometers are
used in implants as continuous fibers which have
been woven to textile form. Woven fibers (i.e., bidi-
rectional continuous fiber system) of the FRC mate-
rial divide the reinforcing effect into the two
directions, which are the directions of the fibers. If the
fiber structure is made of unidirectional continuous
fibers only, the maximal reinforcing effect (Krenchel’s
factor 1) can be obtained [34, 36]. In the presently
Table 1 Clinically important properties of solid biomaterials which have been used in cranioplasty implants excluding in situ cured bone
cements [25–28, 33, 37, 56, 61, 62, 68, 75]
Property AB Titanium HA TCP BG S53P4 PEEK PMMA PE FRC–BG
Resorbability ±a – ? ? ? – – – ±b
Osteoconductivity ±a ? ? ? ? – – – ?
Osteoinductivity ±a – ? ? ? – – – ±c
Neovascularization ±a – ? ? ? – – – ±c
Flexural strength[ 600 MPa – ? – – – – – – ?
Thermal isolation ? – ? ? ? ? ? ? ?
Bone-like radiopacity ? – ? ? ? – – – ?
MRI-compatible ? ± ? ? ? ? ? ? ?
Antimicrobial – – – – ? – – – ?
In situ moldable – ± – – – – – – –
Overlay structure – ? – – – ± – ± ?
AB autologous bone, HA hydroxyapatite, TCP tricalciumphosphate, BG bioactive glass S53P4, PEEK polyetheretherketone, PMMA
polymethylmethacrylate, PE polyethylene, FRC–BG thermoset glass ﬁber-reinforced composite with BG S53P4,MRI magnetic resonance
imaging
a Depending on the biointegration of the bone ﬂap
b FRC: not resorbable, BG S53P4: resorbable
c FRC: no, BG S53P4: yes
Figure 1 Magnetic resonance image of the FRC–BG implant in
reconstruction of excision defect of sphenoid-orbit-temporal
meningioma (arrows are showing the implant). Courtesy: Docent
Ville Vuorinen, Turku University Hospital, Finland.
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used design of FRC cranial implants, both woven
textile form fibers and unidirectional fibers are used
in the implant construction (Fig. 2) [37]. Combination
of the two kinds of fiber systems allows designing a
sandwich structure for the implant with mesh-like
outer and inner surface laminates of the implant.
Inner and outer FRC laminates are connected to each
other by additional continuous unidirectional FRC
bars, which connect the laminates together and pro-
vide high-strength reinforcing element to the
implant. Depending on the implant size and strength
requirements, the implant can contain one or several
unidirectional FRC bars in the construction. Special
features of the FRC cranial implant construction are
mesh-like surface laminate and presence of free space
between the outer and inner laminates, which is
loaded with bioactive modifiers, i.e., particles of
bioactive glass (Fig. 3) [37].
Polymer matrix of FRC material binds the
biostable reinforcing fibers together and protects the
fibers. When FRC construction is loaded, stress is
transferred from resin matrix to be carried by the
reinforcing fibers with specific orientation [34]. During
transferring the load from the polymer matrix to the
stronger fibers, a durable adhesion between the rein-
forcing fibers and the polymer matrix is needed. In the
case of glass fibers with hydroxyl group covered sur-
face, silane coupling agents are used for improving
quality of the adhesive interface [38–42]. Resins are
thermoplastics, thermosets or their combinations in
the form of semi-interpenetrating polymer networks
(semi-IPN). Examples of thermoplastics used in
implants are polyethylene (PE), polyetheretherketone
(PEEK). Examples of thermosets which are utilized as
medical biomaterials are epoxy polymers and bisgly-
cidyl-A-dimethacrylate (BisGMA), triethylene glycol
Figure 2 Computer
tomogram of FRC–BG





and c region of bioactive glass
particles.
Figure 3 Schematic drawing
of the structure of FRC–BG
implant: a mesh-like ﬁber-
reinforced composite laminate,
b particle of bioactive glass.
Number 1 refers to peridural
ossiﬁcation and 2 to
intraimplant ossiﬁcation.
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dimethacrylate (TEGDMA) and urethanedimethacry-
late (UDMA). Thermosets which are polymerized
from the monomers in the presence of silanized glass
fibers form durable chemical adhesion to the glass
fibers, whereas thermoplastics are only physically
interlocked to the surface of fibers [42]. For this reason,
dimethacrylate monomers have been selected to be
used in the FRC–BG cranial implants. In the FRC with
PEEK polymer, the fibers are only physically attached
to the polymer matrix.
Polymerization reaction of monomer systems,
which forms thermoset polymers, is based of free
radical (vinyl) polymerization. Initiation of the poly-
merization is made by autopolymerization or radia-
tion of blue light with wave length of 463 nm [34].
Typically, the autopolymerization is initiated by
peroxide-amine system and the light-initiated poly-
merization is based on initiator system of cam-
phorquinone–amine system. Thermoset polymers
can be post-cured by heat after initial curing which
increases considerably the degree of monomer con-
version, reduces quantity of residual monomers and
improves biocompatibility [43–46]. Optimal post-
curing temperature is close to the glass transition
temperature where there is enough thermal energy in
the system to create free volume, which enables
unreacted carbon–carbon double bonds to form free
radicals and react with each others [47].
Long-term structural success of the reconstructive
composite materials in biological environment
depends to large extent on the hydrolytic stability of
the composite. Hydrolytic stability is dependent on
the stability of polymer matrix, stability of fillers and
stability of the interface between fillers and polymer
matrix. Presently used glass FRC exhibit good long-
term hydrolytic stability, which is based on the sta-
bility of thermoset polymer matrix and glass fibers
and their interface [39, 42, 48]. It is known that good-
quality and surface-purified glass fibers itself exhibit
stability in pH between 3 and 10, meaning that the
pH of tissues in normal and pathological conditions
do not considerably leach the glass fibers and glass
fibers can be considered biostable material in vivo
[49].
Continuous unidirectional FRC, which is used in
the load-bearing part of the FRC–BG implant, has
flexural strength of 1200 MPa, whereas the mesh-like
FRC laminate of the outer and inner surface is having
strength of 400–600 MPa due to lower reinforcing
efficiency factor (Krenchel’s factor) by the
bidirectionally directed fibers [50, 51]. It needs to
emphasize that the load-bearing capacity for the
implant structure comes from the FRC material
properties and from the sandwich structure of the
implant, its shape, its initial screw fixation and finally
from the osseointegration and bone ingrowth. When
the implant of this design is loaded, ductile-type
fracture occurs, i.e., continuous glass fibers do not
break although laminates delaminate from each
other. Bending deformation of the magnitude of
10 mm with a typical-sized cranial implant is still
within the area of elastic deformation, and the
implant receives its original shape after releasing the
external force. Load-bearing capacity of the FRC–BG
implant with size of 112 9 67 mm after being fixed
and osseointegrated in the simulated conditions
reached fracture force of 649 N. Resistance of glass
fibers, polymer matrix and their adhesive interface
has been shown to be good in long-term in vitro
studies during the time of ten years and in vivo with
the follow-up time of more that two years. However,
the FRC material is weakened by ca. 15% during the
first one month time being in water-containing
environment due to plasticization effect of the poly-
mer matrix, but reduction of strength does not con-
tinue in coming years of storing the material in water-
containing solutions [37, 48].
Biocompatibility of FRC material
Biocompatibility of FRC implants is basically related
to the biocompatibility of its major components of
polymer matrix, reinforcing glass fibers and bioactive
glass. Thermoset polymer FRC has been made of
dimethacrylate resin systems but in some cases also
of epoxy resins. Use of epoxy polymer has been
criticized due to potential toxic and allergic effects of
its monomers, which are present as residuals in the
FRC [46, 47, 52]. On the other hand, thermoset poly-
mers made of dimethacrylate monomer systems of
BisGMA have shown good biocompatibility after
careful polymerization before insertion of the mate-
rial to tissues [53, 54] However, when the BisGMA
monomers are allowed to polymerize in situ, for
example, as bone cement, the biocompatibility of the
cement has been questioned [55, 56].
Biological testing of glass FRC by cell culture and
animal testing have shown material’s biocompatibil-
ity. Cell culture study by fibroblasts with silanized
E-glass fibers without the resin matrix has shown no
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signs of cytotoxicity, as it has been also demonstrated
with fibroblasts by agar diffusion cytotoxicity test
and animal experiments [30, 56–62]. In the form of
FRC implant, glass fibers are covered by the ther-
moset polymer matrix and the only areas where the
glass fibers are exposed are located at the margins of
the implant which have been finished mechanically
or by laser ablation. By using osteoblasts on the cell
culture model with FRC implants, no signs of toxic
reactions of the material were found. For instance,
when bone marrow-derived osteoblast-like cells were
harvested and cultured on the FRC material plates
and on commercially pure titanium plates and cell
growth and differentiation kinetics were investi-
gated, similar alkaline phosphatase activities on both
FRC and titanium were observed [62, 63]. Expression
of osteoblastic markers of osteocalcin and bone
sialoprotein indicated that the fastest osteogenic dif-
ferentiation took place on FRC after 7 days. In con-
trast, a slower differentiation process was observed
on titanium. It was concluded that the proliferation
and maturation of osteoblast-like cells on FRC
appeared to be comparable to titanium. Presence of
BG on the implant surface enhanced cell maturation.
A number of preclinical animal experiments have
been carried out to show cell response to FRC in vivo.
In many of the FRC material studies, there have been
additional BG (S53P4) particles on the surface of the
FRC implant [24, 25, 62, 63]. BGs are synthetic
resorbable, biocompatible, osteoconductive–osteoin-
ductive bone substitutes, and some compositions of
BGs have clinically been used because of bone-
bonding capacity, antibacterial and angiogenesis-
promoting properties [64–69]. FRC–BG implant has
been tested by animal tests for cranial implant
applications as well as for orthopedics and oral
implantology. Animal experiments with cranial
implant applications have been made with calvarial
critical size defect model with rabbits with implants
having lamellar FRC structure [30, 59, 60]. Between
the laminates of the implant, there were particles of
bioactive glass for improving osteogenesis, angio-
genesis and antimicrobial properties. Rabbit experi-
ments with newly cut critical size defects showed
new maturating bone ingrowth into the implant
through holes on the implant surface (Fig. 4).
FRCs have the potential for the use as load-bearing
orthopedic implants as well. An experimental animal
study was carried out to test the in vivo performance
of glass FRC implants made of unidirectional glass
fibers and BG (S53P4) surface coverage [24, 29].
Control implants were made of surface-roughened
titanium. Stress-shielding effects of the implants were
predicted by finite element modeling (FEM) [24, 70].
Figure 4 Scanning electron
micrograph of the surface of
FRC–BG implant after in vitro
simulated body ﬂuid testing
showing a surface of ﬁber-
reinforced composite,
b leaching particle of bioactive
glass and c biomineralization




bone ingrowth to the implant
(upper image) [60] bone




Surgical stabilization of bone metastasis in the sub-
trochanteric region of the femur was simulated in a
rabbit model. An oblong subtrochanteric defect of a
standardized size (reducing the torsional strength of
the bones approximately by 66%) was created, and an
intramedullary implant made of titanium or the
FRC–BG was inserted. The contralateral femur served
as the intact control. After healing, the femurs were
harvested and analyzed. The functional recovery was
unremarkable in both groups. FEM studies demon-
strated differences in stress-shielding effects of the
titanium and FRC implants: FRC implants had bone-
like biomechanical properties. The torsional strength
of the fixed bones had returned the level of con-
tralateral intact femurs. Oral implant research has
also utilized glass FRC of BisGMA and TEGDMA
polymer matrix system in studies with experimental
animals. The studies have also shown FRC–BG
implant’s biocompatibility in bone to be comparable
to that of titanium. Addition of BG to the implant
surface increased contact of bone to the implant and
bone maturation [61–63].
Bioactive glass used in cranial implants
Out of several compositions and particle sizes of
bioactive glass, clinically the most potential bioactive
glass in bone augmentation indications is silicate
glass S53P4 with the nominal composition (in wt %)
of Na2O 23; CaO 20; B2O5 4; SiO2 53, and average
particle size on 500 lm [71]. Leaching of BG and the
released ions are behind the biological function of the
glass, and detailed knowledge of these reactions is a
key to selecting BGs as component in implants. BG
S53P4 has shown to fulfill several known require-
ments for osteogenesis and bone remodeling.
Biological function of BG is twofold: release of ions
of calcium and phosphorus is causing biomineral-
ization on the bioactive material surface, like on the
surface of glass FRC and extracellular matrix of new-
forming bone. For cells, at the early stage of osteo-
genesis, released ions from the BG and slightly
increased pH due to ion exchange reactions are
inducing differentiation of mesenchymal stem cells to
cell lines for bone formation [68]. This, in conjunction
with biomineralization promotes bone growth. It is
essential to understand the microenvironment where
cell differentiation occurs. If the pH increases too
much due to ion exchange by the BG, differentiation
of cells does not happen and cells can eventually die.
Too high increase in pH can be because of inadequate
flow of interstitial liquid, too small particle size of BG
and too reactive leaching profile of BG due to its
composition [72]. Level of pH where differentiation
of mesenchymal stem cells is hindered is around 8.5,
whereas the effective differentiation can be seen in
pH of 7.8–8.0 [68, 72]. There is also in vitro obtained
information that BG can induce vascularization, and
indeed, histological analysis of new bone around BG
shows the presence of blood vessels [37, 68, 73].
With regard to osseointegration, i.e., bonding
between the BG of the implant and tissue, a series of
reactions starting at the glass surface followed by a
series of biological reactions are occurring. The dif-
ferent reaction steps taking place at the glass surface
depend mainly on the glass composition but also on
the surface topography, surface area of glass, and
flow of the interstitial fluid in the microenvironment
close to the glass surfaces. In the subsequent steps,
calcium and phosphate from the solution, and
migrating from the bulk glass, form first amorphous
hydroxyapatite and then crystallize at carbonate
substituted hydroxyapatite layer (HA) at the glass
surface (Fig. 3). This HA layer is compatible with the
biological apatite and provides an interfacial bonding
between the material and tissue.
Antibacterial properties of the glasses are attrib-
uted to the local rise of pH level and increased ion
concentration causing increased osmotic pressure
[74]. The US Food and Drug Administration (FDA)
approved BG 45S5 and BG S53P4 for certain clinical
applications where antimicrobial properties are
required. Increase in the alkalinity by bioactive glass
45S5 is higher than by glass S53P4, and therefore
glass 45S5 is considered to be more effective in terms
of antimicrobial properties. On the other hand, a
balance between antimicrobial properties, i.e.,
increase in pH and moderate alkalinity and ion
release and osteogenicity, has been found with BG
S53P5. In vitro conditions in the presence of BG S53P4
showed the increase in pH to the level of 7.9 [35].
Antimicrobial efficiency has been shown for more
than 20 microbe species, including Staphylococcus
aureus and Staphylococcus epidermis, which are the
most common pathogens in periprosthetic infections
[75, 76]. Antimicrobial properties have been benefi-
cial also in augmentation of bone defects which are
prone for infections [77, 78].
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Clinical use and development stages
of FRC–BG implants
To overcome discomfort and pain by cranial and
facial bone reconstructions based on autologous bone
transplants, and problems related to biomaterial
implants, patient-specific FRC–BG cranial implants
were started to be used first time in 2007 [23]. Before
the time FRC–BG implants, the first-generation
implants were made of bulk polymethylmethacrylate
(PMMA) which has been polymerized ex vivo and
covered from the surface with exposing particles of
BG S53P4 [79]. Based on the clinical experiences with
the PMMA implants, further improvements in terms
of allowing osteogenesis and vascularization to occur
inside the implant and to have thinner and cosmeti-
cally more pleasant looking margins for the implants,
studies of FRC–BG implants started [30, 59, 60, 80, 81].
The first FRC–BG implants were loaded with BG
S53P4 and the implant structure had dense outer and
inner surface laminates made of glass FRC fabric and
between the layers there was porous glass FRC par-
ticles of BG. Implant design allowed blood penetra-
tion only by capillary forces from the sides of the
implant to occur, and therefore only ca. 15 mm from
the margin of the implant became in contact with
blood [28]. Postoperative positron emission computer
tomography (PET-CT) examination with (18F)-fluo-
ride marker has demonstrated activity of the
mineralizing bone by osteoblasts, especially at the
margins of the implant into which the blood was
penetrated by capillary forces (Fig. 5). When implant
of that kind had been analyzed more in detail after
being in situ for two years and three months, 3D CT
reconstructions demonstrated ossification on the
lover surface of implant which was considered as
peridural ossification (Fig. 6). Histological analysis
showed blood vessels and clusters of osteoblasts
along the collagenous fibers with osteoid formation
and clusters of bone-like hard tissue. Osteoblasts
were also found on the surface of the implant with
osteoid production. However, this implants design
with blood penetration only to the marginal area of
the implant showed the biological activity on the
implant margins only, which emphasized importance
of the blood penetration into the implant. Clinical
follow-up study of this type of FRC–BG implant
showed higher survival estimates than for other
implant materials and autologous bone in of retro-
spective study material (Fig. 7) [81].
Based on the observations of the first-stage FRC–
BG implants, the implant design was changed to be
more mesh-like in structure. Change in the design
was made for having better interstitial liquid perfu-
sion through the implant by pulsatile movement of
dura mater, which facilitated stem cells and growth
factors from the refreshed bone margins at the
operation site to penetrate into the implant and
Figure 5 Positron emission
tomogram with ﬂuoride
marker showing the FRC–BG
implant (block arrow), margins
of the implant (white arrows),
margins of the original bone
defect (dotted lines) and
histological section (HE
staining) of the osteoblasts
inside the implant which had
absorbed blood during the
surgical operation to install the
implant [37].
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become in contact to BG particles, and promote
osteogenesis. Recent data indicate that shear stress
and circumferential stretch by pulsatile flow affects
mesenchymal stem cell differentiation toward
endothelial linea. Release of ions and related increase
in pH by the BG enhanced osteogenesis and vascu-
larization to occur in the implant and make the
implant microenvironment bacteriostatic. For
instance, phosphate ions have shown to have an
important role in osteogenesis [82]. Interestingly, BG
S53P4 shows higher release of phosphate ions than
BG 45S5 [35], which may be one factor together with
the only moderate increase of pH behind the good
clinical function of the BG S53P4 compared to BG
45S5. Mechanical strength for the implant was
obtained from the biostable glass FRC laminates of
inner and outer surfaces of the implants and contin-
uous unidirectional glass FRC bars which connected
laminates to each other and provided space for BG
particles. The present design of FRC–BG cranial
implant has received good acceptance by the sur-
geons, and it was approved for clinical use as patient-
specific implant and standard-shaped implant in
Europe in 2014.
Future trends
There is a trend toward nonmetallic load-bearing
implants in all fields of bone surgery. In cranial
implantology, the driving forces for nonmetallic
implant are requirements of medical imaging sys-
tems, requirements of radiation therapy and need to
decrease number of periprosthetic infections and
infections of resorbing autologous bone flaps. In the
implant applications of long bones, namely in
orthopedics and traumatology, driving forces are in
need to eliminate stress-shielding and fatigue failures
of implants. Glass FRC materials are fulfilling
requirements of mechanical strength and biome-
chanical matching to the properties of bone, and at
the same time allowing bioactive modification by
presence of BG in the implant have proven to be
potential material bone surgery. It looks that the
development of the implant materials and implant
constructions is going on the track of bioactive com-
posites with high-aspect-ratio fillers. Considerable
amount of research work has been put already on
these new materials, and coming research is focusing
on optimizing the biomechanical properties, function
bioactive compounds and antimicrobial properties of
the implants, as well as searching novel applications
where bone and soft tissue applications for bioactive
glasses can be combined [83–86].
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